Medicare Part D coverage · methscopolamine bromide · RxCUI 403914
methscopolamine bromide 5 MG Oral Tablet
Per the CMS 2026 Part D formulary file, methscopolamine bromide 5 MG Oral Tablet is covered by 2,050 Medicare Part D plans (40.6% of enrollable products), averaging Tier 3.1, with prior authorization required on 9.6% of covering formularies.
- 40.6%
- Plan coverage
- 2,050
- Plans covering
- T3.1
- Avg tier
- 9.6%
- Prior auth required
What the CMS Formulary Data Shows for methscopolamine bromide 5 MG Oral Tablet
Per the CMS 2026 Part D formulary file, methscopolamine bromide 5 MG Oral Tablet (RxNorm concept RXCUI 403914, generic name methscopolamine bromide) appears on 73 distinct formulary files spanning 2,050 Medicare Part D plan offerings - 40.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.1.
Real-world access to methscopolamine bromide 5 MG Oral Tablet depends on utilization management as much as tier placement: 9.6% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,596 Part D beneficiaries filled methscopolamine bromide 5 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $836,854 and an average per-beneficiary annual cost of $524.34. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry methscopolamine bromide 5 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 73
- Plans covering
- 2,050
- Coverage rate
- 40.6%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 9.6% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,596
- Total spending
- $836,854
- Avg per beneficiary
- $524.34
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering methscopolamine bromide 5 MG Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| CareAdvantage (HMO D-SNP) | SAN Mateo Health Commission | T1 | No | $0 | CA |
| Gold Coast Health Plan Total Care Advantage (HMO D-SNP) | Ventura County Medi-Cal Managed Care Commission | T1 | No | $0 | CA |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Health Care Service Corporation | T1 | No | $0 | NM |
| Blue Cross MA Dual Care Plus Preferred (PPO D-SNP) | Health Care Service Corporation | T1 | No | $0 | NM |
| SecureBlue (HMO D-SNP) | HMO Minnesota | T1 | No | $0 | MN |
| Hamaspik Medicare Choice (HMO D-SNP) | Hamaspik, Inc. | T1 | No | $0 | NY |
| PHP (HMO C-snp) | Aids Healthcare Foundation | T1 | No | $0 | CA |
| VNS Health Total (HMO D-SNP) | VNS Choice | T1 | No | $0 | NY |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $0 | PA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $0 | PA |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Health Options West Virginia Inc. | T1 | Yes | $0 | WV |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Bcbsd, Inc. | T1 | Yes | $0 | DE |
| Leon MediExtra (HMO) | Leon Health, Inc. | T1 | No | $0 | FL |
| Leon MediDual (HMO D-SNP) | Leon Health, Inc. | T1 | No | $0 | FL |
| Leon MediMore (HMO) | Leon Health, Inc. | T1 | No | $0 | FL |
| Leon MediMax (HMO D-SNP) | Leon Health, Inc. | T1 | No | $0 | FL |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Hcsc Insurance Services Company | T1 | No | $4.80 | TX |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Florida Inc | T1 | No | $4.80 | FL |
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is methscopolamine bromide 5 MG Oral Tablet covered by Medicare Part D?
Yes, methscopolamine bromide 5 MG Oral Tablet is covered by 2,050 Medicare Part D plans (40.6% of all Part D formularies).
What tier is methscopolamine bromide 5 MG Oral Tablet on Medicare Part D plans?
methscopolamine bromide 5 MG Oral Tablet averages Tier 3.1 across Part D plans, ranging from Tier 1 to Tier 4.
Does methscopolamine bromide 5 MG Oral Tablet require prior authorization?
9.6% of Part D formularies require prior authorization for methscopolamine bromide 5 MG Oral Tablet. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on methscopolamine bromide 5 MG Oral Tablet?
In 2023, total Medicare Part D spending on methscopolamine bromide 5 MG Oral Tablet was $836,854, covering 1,596 beneficiaries. The average spend per beneficiary was $524.34.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
Similar prior-authorization rate
- 1 ML denosumab-nxxp 60 MG/ML Prefilled Syringe [Bildyos] 9.6% PA
- doxycycline hyclate 100 MG Injection 9.5% PA
- ceftazidime 200 MG/ML Injectable Solution [Tazicef] 9.4% PA
- 100 ML ciprofloxacin 2 MG/ML Injection 9.8% PA
- azithromycin 500 MG Injection 9.8% PA
- ampicillin 1000 MG / sulbactam 500 MG Injection 9.3% PA